Eton Pharmaceuticals Inc. (ETON) Misses Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts ETON Hot Sheet
Join SI Premium – FREE
Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q3 EPS of $0.04, $0.07 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $22.5 million versus the consensus estimate of $20.27 million.
For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US Treasury: 'Authorizing Wind Down Activities...the Offloading of Cargo Involving Certain Persons or Vessels Blocked on October 21, 2026'
- Cleveland-Cliffs (CLF) PT Raised to $18 at B.Riley
- Active options: SPCX NVDA AAPL NFLX MU TSLA AMZN GOOGL AMD CRWV
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
